Document is current
Any future updates will be listed below
-
Authors
Zaninelli, Silvia
Cattaneo, Irene
Valgardsdottir, Rut
Frapolli, Roberta
Bello, Ezia
Meroni, Marina
Gianatti, Andrea
Panna, Silvia
Rizzo, Paola
Tomasoni, Susanna
D’Incalci, Maurizio
Introna, Martino
Golay, Josée
Rambaldi, Alessandro
-
Funding
Funding for this research was provided by:
Associazione Italiana Ricerca contro il Cancro (AIRC 5x1000 grant (Project ISM, n° 21147))
Fondazione AIRC per la ricerca sul cancro ETS (22791, “Innovative CAR Therapy Platforms” (INCAR))
Fondazione Regionale per la Ricerca Biomedica (Project N°CP2_10/ 2018 “Plagencell”)
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 5 August 2025
First Online: 13 September 2025
Declarations
:
: AR has received honoraria for lectures or presentations from Novartis, Amgen, Pfizer, Astellas, Jazz, Janssen, Incyte, Kite-Gilead, Omeros, Sanofi, Italfarmaco; has received support for attending meetings and/or travel from Novartis, Amgen, Pfizer, Astellas, Jazz, Janssen, Incyte, Kite-Gilead, Omeros; participated on a Data Safety Monitoring Board or Advisory Board from Novartis, Amgen, Pfizer, Astellas, Jazz, Janssen, Incyte, Kite-Gilead, Roche, Omeros, Sanofi, Italfarmaco.
